Metabolic Pathway Tracer for Breast Cancer
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Research shows that using 13C6-glucose can help track how cancer cells process glucose, which is important for understanding tumor metabolism. This method has been used to study glucose metabolism in different types of cancer, suggesting it could be useful in assessing breast cancer as well.
12345Research involving U-13C-glucose in mice has shown it can be used safely to trace metabolic processes without causing stress or harm. However, specific safety data for humans is not provided in the available studies.
12467U-13C-glucose is unique because it acts as a tracer to study the metabolic pathways in breast cancer cells, helping researchers understand how these cells process glucose differently from normal cells. This approach is different from standard treatments as it focuses on mapping cancer metabolism rather than directly targeting cancer cells for destruction.
128910Eligibility Criteria
This trial is for individuals with HR+/HER2- breast cancer, who haven't had neoadjuvant therapy and are set for curative surgery. They must be willing to provide tissue samples during surgery and not be part of another clinical study or have other active cancers.Inclusion Criteria
Exclusion Criteria